Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Issuers ranked
1,503
Showing 50 of 1,503
Quality filters
10+ trades
≥3 insiders, 50% price coverage
Window
5y trailing
Trade date filter
| # | Ticker | Issuer | Trades | Insiders | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|---|
| 1 | MNPR | Monopar Therapeutics | 16/27 | 11 | 69% | +499.0% | +663.3% | +944.8% | -43.1% |
| 2 | TGEN | Tecogen Inc. | 36/55 | 9 | 100% | +396.8% | +269.0% | +1019.3% | +42.3% |
| 3 | QDMI | Qdm International Inc. | 17 | 5 | 29% | +372.9% | -55.1% | +1400.0% | -55.1% |
| 4 | RLMD | Relmada Therapeutics, Inc. | 25/41 | 5 | 32% | +347.5% | -44.1% | +1281.1% | -91.0% |
| 5 | PRLD | Prelude Therapeutics Inc | 15/26 | 9 | 100% | +243.4% | +305.7% | +384.2% | +73.8% |
| 6 | SEPN | Septerna, Inc. | 52/61 | 17 | 100% | +230.0% | +363.2% | +443.3% | +7.6% |
| 7 | GTHP | Guided Therapeutics Inc | 11/14 | 3 | 100% | +203.3% | +237.3% | +239.8% | +75.0% |
| 8 | TKNO | Alpha Teknova, Inc. | 12/16 | 8 | 83% | +201.1% | +250.8% | +250.8% | -48.3% |
| 9 | NANX | Nanophase Technologies Corp | 65/87 | 4 | 100% | +184.2% | +163.9% | +454.9% | +111.4% |
| 10 | IAUX | I-80 Gold Corp. | 13/22 | 10 | 100% | +177.8% | +164.9% | +193.0% | +164.9% |
| 11 | AISP | Airship Ai Holdings, Inc. | 19/31 | 5 | 89% | +163.0% | +189.2% | +305.3% | -38.1% |
| 12 | TOI | Oncology Institute, Inc. | 38/75 | 18 | 84% | +158.2% | +70.0% | +1797.4% | -51.1% |
| 13 | GDRZF | Gold Reserve Ltd | 80 | 5 | 100% | +140.8% | +136.6% | +204.7% | +93.8% |
| 14 | HOVR | New Horizon Aircraft Ltd. | 54/87 | 5 | 74% | +132.5% | +159.2% | +763.5% | -334.0% |
| 15 | FTEK | Fuel Tech, Inc. | 12/15 | 3 | 100% | +131.3% | +86.9% | +259.4% | +13.3% |
| 16 | UEC | Uranium Energy Corp | 14/15 | 4 | 100% | +119.8% | +177.5% | +177.5% | +13.9% |
| 17 | INBX | Inhibrx Biosciences, Inc. | 29/53 | 13 | 76% | +115.0% | +87.7% | +474.8% | -24.9% |
| 18 | PETV | Petvivo Holdings, Inc. | 49/55 | 3 | 94% | +114.8% | +119.6% | +200.9% | -41.5% |
| 19 | ATYR | Atyr Pharma Inc | 11/19 | 6 | 82% | +114.3% | +174.6% | +253.5% | -138.8% |
| 20 | LIDR | Aeye, Inc. | 19/32 | 8 | 100% | +102.4% | +79.3% | +200.0% | +26.8% |
| 21 | USAU | U.S. Gold Corp. | 13/26 | 8 | 100% | +99.9% | +94.2% | +153.6% | +79.1% |
| 22 | CERO | Cero Therapeutics Holdings, Inc. | 29 | 5 | 100% | +99.6% | +99.9% | +100.0% | +97.3% |
| 23 | CDT | Cdt Equity Inc. | 54 | 7 | 100% | +99.5% | +99.5% | +99.7% | +99.4% |
| 24 | PHAT | Phathom Pharmaceuticals, Inc. | 24/32 | 8 | 71% | +96.9% | +51.2% | +427.9% | -137.2% |
| 25 | MPAA | Motorcar Parts America Inc | 33/37 | 16 | 100% | +93.9% | +90.0% | +123.7% | +17.6% |
| 26 | DRCT | Direct Digital Holdings, Inc. | 53/87 | 5 | 100% | +93.5% | +97.6% | +99.0% | +86.0% |
| 27 | CTNT | Cheetah Net Supply Chain Service Inc. | 11 | 6 | 100% | +91.8% | +92.3% | +99.1% | +71.2% |
| 28 | FXLV | F45 Training Holdings Inc. | 32 | 3 | 100% | +89.8% | +89.9% | +91.6% | +87.6% |
| 29 | ILLR | Triller Group Inc. | 22 | 3 | 100% | +89.6% | +90.3% | +98.7% | +76.4% |
| 30 | MULN | Mullen Automotive Inc. | 19/32 | 10 | 95% | +89.4% | +100.0% | +100.0% | -100.0% |
| 31 | NAUT | Nautilus Biotechnology, Inc. | 12/20 | 6 | 58% | +89.4% | +74.6% | +305.3% | -61.7% |
| 32 | SOBR | Sobr Safe, Inc. | 18/21 | 3 | 94% | +87.7% | +98.7% | +99.3% | -98.5% |
| 33 | VSH | Vishay Intertechnology Inc | 14/16 | 11 | 93% | +87.3% | +128.2% | +159.4% | -5.0% |
| 34 | DRUG | Bright Minds Biosciences Inc. | 35/38 | 3 | 100% | +86.3% | +76.8% | +130.6% | +1.4% |
| 35 | MGNX | MacRogenics Inc | 17/20 | 7 | 100% | +85.0% | +88.8% | +94.0% | +40.6% |
| 36 | BTAI | Bioxcel Therapeutics, Inc. | 49/53 | 8 | 100% | +84.3% | +92.3% | +96.2% | +70.8% |
| 37 | BUKS | Butler National Corp | 95/126 | 6 | 99% | +84.0% | +73.0% | +154.6% | -127.0% |
| 38 | SONM | Sonim Technologies Inc | 14/18 | 8 | 100% | +83.7% | +84.9% | +85.0% | +79.8% |
| 39 | MBX | Mbx Biosciences, Inc. | 44/56 | 26 | 41% | +83.0% | -55.0% | +446.8% | -55.0% |
| 40 | BSLK | Bolt Projects Holdings, Inc. | 13/24 | 6 | 92% | +82.6% | +98.9% | +99.1% | -97.0% |
| 41 | LGCY | Legacy Education Inc. | 40/46 | 6 | 100% | +82.3% | +95.0% | +148.5% | +8.8% |
| 42 | MYSZ | My Size, Inc. | 11/17 | 4 | 100% | +82.3% | +82.3% | +82.3% | +82.3% |
| 43 | MICS | Singing MacHine Co Inc | 26/44 | 6 | 85% | +81.3% | +97.7% | +98.6% | -9.7% |
| 44 | YBGJ | Yubo International Biotech Ltd | 19 | 3 | 100% | +81.2% | +84.9% | +84.9% | +14.7% |
| 45 | BKTI | Bk Technologies Corp | 26/33 | 10 | 58% | +78.6% | +228.5% | +291.8% | -180.7% |
| 46 | AVTE | Aerovate Therapeutics, Inc. | 58 | 13 | 91% | +78.2% | +90.6% | +199.7% | -85.6% |
| 47 | TVGN | Tevogen Bio Holdings Inc. | 10/14 | 3 | 100% | +78.2% | +85.7% | +88.5% | +46.0% |
| 48 | MYGN | Myriad Genetics Inc | 13/21 | 12 | 100% | +77.5% | +78.2% | +84.9% | +67.4% |
| 49 | HFUS | Hartford Creative Group, Inc. | 12 | 5 | 75% | +77.3% | +68.9% | +176.4% | -79.3% |
| 50 | FDMT | 4d Molecular Therapeutics, Inc. | 38/48 | 12 | 100% | +76.8% | +77.8% | +90.1% | +55.3% |
Showing 1-50 of 1,503